focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 23.00
Ask: 26.00
Change: 0.00 (0.00%)
Spread: 3.00 (13.043%)
Open: 24.50
High: 0.00
Low: 0.00
Prev. Close: 24.50
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Lansdowne and Barryroe slump after licence blow

Mon, 22nd May 2023 10:12

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Norman Broadbent PLC, up 23% at 6.45 pence, 12-month range 3.00p-6.84p. The recruitment firm says revenue in the first quarter of 2023 jumped 67% annually to GBP2.9 million from GBP1.8 million. Net fee income rises 66% to GBP2.4 million from GBP1.5 million. Looking ahead, Norman Broadbent notes "excellent forward momentum", with a pipeline of contracted revenue at the end of the quarter of GBP2.6 million. The company expects to publish its results for 2022 later this month.

----------

Oncimmune Holdings PLC, up 9.5% to 40.41p, 12-month range 34.00p-106.09p. The immuno-diagnostics developer says it has sold its wholly-owned subsidiaries, Oncimmune Ltd and Oncimmune Europe GmbH to Freenome Holdings, for GBP13 million in cash. Oncimmune will continue to operate its ImmunoINSIGHTS business, primarily through its subsidiary Oncimmune Germany GmbH. Also says Oncimmune Germany and Freenome have signed a long-term have signed a master services agreement.

----------

AIM - LOSERS

----------

Lansdowne Oil & Gas PLC, down 56% at 0.19p, 12-month range 0.17p-0.64p; and Barryroe Offshore Energy PLC, down 42% at 1.08p, 12-month range 0.90p-4.13p. On Friday, Barryroe said a government minister in Ireland is not "satisfied with the financial capability" of those involved in an oil and gas lease application. The company, chasing a Dublin government green light for the SEL1/11 licence, said it received correspondence from Eamon Ryan, Ireland's minister for the Department of the Environment, Climate & Communications. SEL1/11 houses the Barryroe field. Barryroe Offshore owns an 80% stake in the asset, while Lansdowne Oil & Gas PLC owns 20%. On Monday, Lansdowne says it has received no direct correspondence from the Irish government department regarding the decision. However, it notes that it has verified the content directly with Barryroe. Lansdowne says that it has engaged with external legal counsel to assess its legal rights and the potential options available, including pursuing legal proceedings, for the purposes of protecting its investment in the Barryroe project.

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 Sep 2020 13:49

Oncimmune announces autoantibody profiling collaboration

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has signed an autoantibody profiling collaboration with an unnamed "leading global biopharmaceutical company", it announced on Wednesday, which it said had "extensive experience" in developing novel immune checkpoint inhibitors (CPIs).

Read more
27 Jul 2020 18:11

IN BRIEF: Oncimmune Notes Expanded Profiling Contract With Roche

IN BRIEF: Oncimmune Notes Expanded Profiling Contract With Roche

Read more
27 Jul 2020 09:22

Roche extends scope and value of contract with Oncimmune

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced on Monday that Roche has exercised its option to increase the scope and value of the cornerstone contract, initially announced on 28 May.

Read more
2 Jul 2020 06:54

IN BRIEF: Oncimmune's EarlyCDT Gets Marketing Authorisation In Brazil

IN BRIEF: Oncimmune's EarlyCDT Gets Marketing Authorisation In Brazil

Read more
5 Jun 2020 14:10

UK DIRECTOR DEALINGS SUMMARY: Avast Non-Exec Sells 500,000 Shares

UK DIRECTOR DEALINGS SUMMARY: Avast Non-Exec Sells 500,000 Shares

Read more
4 Jun 2020 13:19

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

Read more
4 Jun 2020 10:50

Oncimmune expects to report further strong top-line growth

(Sharecast News) - Immunodiagnostics group Oncimmune Holdings said on Thursday that it expects to report further strong top-line growth in its current trading year.

Read more
28 May 2020 15:32

Oncimmune Inks Further Roche Contract Focused On Immunotherapy Trials

Oncimmune Inks Further Roche Contract Focused On Immunotherapy Trials

Read more
12 May 2020 16:42

Oncimmune Signs Drug Development Deal With US Biopharmaceutical Firm

Oncimmune Signs Drug Development Deal With US Biopharmaceutical Firm

Read more
12 May 2020 15:32

Oncimmune signs collaboration deal with US biopharma company

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has signed an antigen-targeting collaboration, it announced on Tuesday, to support drug development with a "leading", unnamed United States biopharmaceutical company, which is developing novel therapies based on the human immune response.

Read more
6 May 2020 14:57

UK DIRECTOR DEALINGS SUMMARY: Burford Capital Chiefs Spend GBP425,000

UK DIRECTOR DEALINGS SUMMARY: Burford Capital Chiefs Spend GBP425,000

Read more
5 May 2020 11:50

UK EXECUTIVE CHANGE SUMMARY: Sigma Capital Taps Former Countryside CEO

UK EXECUTIVE CHANGE SUMMARY: Sigma Capital Taps Former Countryside CEO

Read more
18 Mar 2020 18:09

DIRECTOR DEALINGS SUMMARY: Wizz Air Chair Buys GBP700,000 In Shares

DIRECTOR DEALINGS SUMMARY: Wizz Air Chair Buys GBP700,000 In Shares

Read more
18 Mar 2020 07:30

UK Advisory Body Gives Oncimmune's Lung Cancer Test Positive Review

UK Advisory Body Gives Oncimmune's Lung Cancer Test Positive Review

Read more
4 Mar 2020 12:57

Oncimmune EarlyCDT Lung Test Launched In US By Commercial Partner

Oncimmune EarlyCDT Lung Test Launched In US By Commercial Partner

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.